1. Should isolated morbid obesity influence the decision to operate in hip and knee arthroplasty?
- Author
-
Peter F. Crookes, Janet C. Hill, David E. Beverland, John E. McCaffrey, Aleksander Machowicz, Gillian Turner, and Roslyn S. Cassidy
- Subjects
Orthopedic surgery ,030222 orthopedics ,medicine.medical_specialty ,hip ,business.industry ,Activity Level ,medicine.medical_treatment ,General Engineering ,knee ,Arthroplasty ,morbid obesity ,Morbid obesity ,03 medical and health sciences ,Return to Work ,0302 clinical medicine ,Physical therapy ,Revision Knee Arthroplasty ,Medicine ,arthroplasty ,030212 general & internal medicine ,Revision Hip Arthroplasty ,business ,RD701-811 - Abstract
Aims We studied the outcomes of hip and knee arthroplasties in a high-volume arthroplasty centre to determine if patients with morbid obesity (BMI ≥ 40 kg/m2) had unacceptably worse outcomes as compared to those with BMI < 40 kg/m2. Methods In a two-year period, 4,711 patients had either total hip arthroplasty (THA; n = 2,370), total knee arthroplasty (TKA; n = 2,109), or unicompartmental knee arthroplasty (UKA; n = 232). Of these patients, 392 (8.3%) had morbid obesity. We compared duration of operation, anaesthetic time, length of stay (LOS), LOS > three days, out of hours attendance, emergency department attendance, readmission to hospital, return to theatre, and venous thromboembolism up to 90 days. Readmission for wound infection was recorded to one year. Oxford scores were recorded preoperatively and at one year postoperatively. Results On average, the morbidly obese had longer operating times (63 vs 58 minutes), longer anaesthetic times (31 vs 28 minutes), increased LOS (3.7 vs 3.5 days), and significantly more readmissions for wound infection (1.0% vs 0.3%). There were no statistically significant differences in either suspected or confirmed venous thromboembolism. Improvement in Oxford scores were equivalent. Conclusion Although morbidly obese patients had less favourable outcomes, we do not feel that the magnitude of difference is clinically significant when applied to an individual, particularly when improvement in Oxford scores were unrelated to BMI. Cite this article: Bone Jt Open 2021;2(7):515–521.
- Published
- 2021
- Full Text
- View/download PDF